Inhibitory Effect of Nifedipine on Aldose Reductase Delays Cataract Progression

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2023 Jul 3

PMID 37395794

Authors

Alaparthi Malini Devi

Venu Sankeshi

Arugonda Ravali

Srinivas Bandaru

Vinay Kumar Theendra

Someswar Rao Sagurthi

Affiliations

Soon will be listed here.

Abstract

Aldose reductase (ALR2) is a rate-limiting component of the polyol pathway, which is essential for the NADPH-mediated conversion from glucose to sorbitol. ALR2 dysregulation has been linked to α-crystallin aggregation, increased oxidative stress, and calcium inflow, all of which contribute to a diabetic cataract. Given its crucial role in occular pathologies, ALR2 has emerged as a promising target to treat oxidative stress and hyperglycaemic condition which form the underlying cause of diabetic cataracts. However, several of them had issues with sensitivity and specificity to ALR2, despite being screened as effective ALR2 inhibitors from a wide range of structurally varied molecules. The current study investigates the inhibitory potential of Nifedipine, an analog of the dihydro nicotinamide class of compounds against ALR2 activity. The enzyme inhibition studies were supported by in vitro biomolecular interactions, molecular modeling approaches, and in vivo validation in diabetic rat models. Nifedipine demonstrated appreciable inhibitory potential with the purified recombinant hAR (human aldose reductase; with an IC50 value of 2.5 µM), which was further supported by Nifedipine-hAR binding affinity (Kd = 2.91 ± 1.87 × 10 M) by ITC and fluorescence quenching assays. In the in vivo models of STZ-induced diabetic rats, Nifedipine delayed the onset progression of cataracts by preserving the antioxidant enzyme activity (SOD, CAT, and GPX GSH, TBARS, and protein carbonyls) and was shown to retain the α-crystallin chaperone activity by reducing the calcium levels in the diabetic rat lens. In conclusion, our results demonstrate effective inhibition of ALR2 by Nifedipine, resulting in amelioration of diabetic cataract conditions by lowering oxidative and osmotic stress while retaining the chaperone activity of α-crystallins. The present study could be envisaged to improve the eye condition in older adults upon Nifedipine treatment.

References

Balendiran G, Rajkumar B . Fibrates inhibit aldose reductase activity in the forward and reverse reactions. Biochem Pharmacol. 2005; 70(11):1653-63. DOI: 10.1016/j.bcp.2005.06.029. View

Clark J, Huang Q . Modulation of the chaperone-like activity of bovine alpha-crystallin. Proc Natl Acad Sci U S A. 1996; 93(26):15185-9. PMC: 26378. DOI: 10.1073/pnas.93.26.15185. View

Ellman G . Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82(1):70-7. DOI: 10.1016/0003-9861(59)90090-6. View

Ghahramani M, Yousefi R, Khoshaman K, Alavianmehr M . The impact of calcium ion on structure and aggregation propensity of peroxynitrite-modified lens crystallins: new insights into the pathogenesis of cataract disorders. Colloids Surf B Biointerfaces. 2014; 125:170-80. DOI: 10.1016/j.colsurfb.2014.11.002. View

Gopinath G, Sankeshi V, Perugu S, Alaparthi M, Bandaru S, Pasala V . Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors. Eur J Med Chem. 2016; 124:750-762. DOI: 10.1016/j.ejmech.2016.08.070. View

Kametaka S, Kasahara T, Ueo M, Takenaka M, Saito M, Sakamoto K . Effect of nifedipine on severe experimental cataract in diabetic rats. J Pharmacol Sci. 2008; 106(4):651-8. DOI: 10.1254/jphs.fp0072294. View

Khan M, Qais F, Rehman M, Ismail M, Alokail M, Altwaijry N . Mechanistic inhibition of non-enzymatic glycation and aldose reductase activity by naringenin: Binding, enzyme kinetics and molecular docking analysis. Int J Biol Macromol. 2020; 159:87-97. DOI: 10.1016/j.ijbiomac.2020.04.226. View

Koch C, Heine A, Klebe G . Tracing the detail: how mutations affect binding modes and thermodynamic signatures of closely related aldose reductase inhibitors. J Mol Biol. 2010; 406(5):700-12. DOI: 10.1016/j.jmb.2010.11.058. View

Kumar Pasala V, Gudipudi G, Sankeshi V, Basude M, Gundla R, Singh Jadav S . Design, synthesis and biological evaluation of selective hybrid coumarin-thiazolidinedione aldose reductase-II inhibitors as potential antidiabetics. Bioorg Chem. 2021; 114:104970. DOI: 10.1016/j.bioorg.2021.104970. View

10.

Lawrence R, Sunde R, Schwartz G, Hoekstra W . Glutathione peroxidase activity in rat lens and other tissues in relation to dietary selenium intake. Exp Eye Res. 1974; 18(6):563-9. DOI: 10.1016/0014-4835(74)90062-1. View

11.

Lee A, Chung S . Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999; 13(1):23-30. DOI: 10.1096/fasebj.13.1.23. View

12.

Liu K, Lyu L, Chin D, Gao J, Sun X, Shang F . Altered ubiquitin causes perturbed calcium homeostasis, hyperactivation of calpain, dysregulated differentiation, and cataract. Proc Natl Acad Sci U S A. 2015; 112(4):1071-6. PMC: 4313858. DOI: 10.1073/pnas.1404059112. View

13.

Maddala R, Nagendran T, de Ridder G, Schey K, Rao P . L-type calcium channels play a critical role in maintaining lens transparency by regulating phosphorylation of aquaporin-0 and myosin light chain and expression of connexins. PLoS One. 2013; 8(5):e64676. PMC: 3667166. DOI: 10.1371/journal.pone.0064676. View

14.

Mak I, Weglicki W . Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res. 1990; 66(5):1449-52. DOI: 10.1161/01.res.66.5.1449. View

15.

Marklund S, Marklund G . Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974; 47(3):469-74. DOI: 10.1111/j.1432-1033.1974.tb03714.x. View

16.

Nair J, Howlin S, Porter J, Rimmer T . Using low dose oral nifedipine to prevent cancellation of cataract surgery for patients with preoperative hypertension. Eye (Lond). 2008; 23(4):989-90. DOI: 10.1038/eye.2008.72. View

17.

Ohkawa H, Ohishi N, Yagi K . Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2):351-8. DOI: 10.1016/0003-2697(79)90738-3. View

18.

Rao P, Horwitz J, Zigler Jr J . Chaperone-like activity of alpha-crystallin. The effect of NADPH on its interaction with zeta-crystallin. J Biol Chem. 1994; 269(18):13266-72. View

19.

Reddy G, Das K, Petrash J, Surewicz W . Temperature-dependent chaperone activity and structural properties of human alphaA- and alphaB-crystallins. J Biol Chem. 2000; 275(7):4565-70. DOI: 10.1074/jbc.275.7.4565. View

20.

Rhodes J, Sanderson J . The mechanisms of calcium homeostasis and signalling in the lens. Exp Eye Res. 2008; 88(2):226-34. DOI: 10.1016/j.exer.2008.10.025. View